Letter, 2024

Semaglutide and Cardiovascular Outcomes REPLY

NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, Volume 390, 8, Pages 768-769,

Contributors

Lincoff, A. Michael 0000-0001-8175-2121 (Corresponding author) [1] Ryan, Donna H. [2] [3] [4] Esbjerg, Sille [5]

Affiliations

  1. [1] Cleveland Clin, Cleveland, OH 44106 USA
    2. [NORA names: United States; America, North; OECD];
  2. [2] Pennington Biomed Res Ctr, Baton Rouge, LA USA
    3. [NORA names: United States; America, North; OECD];
  3. [3] Pennington Biomed Res Ctr, Baton Rouge, LA USA
    4. [NORA names: United States; America, North; OECD];
  4. [4] Pennington Biomed Res Ctr, Baton Rouge, LA USA
    5. [NORA names: United States; America, North; OECD];
  5. [5] NOVO Nordisk, Soborg, Denmark
    6. [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+